Peter Prock

Independent Director

Peter Prock, co-founder and managing partner of Albrecht, Prock & Partners started his pharmaceutical career at Sandoz and worked in several positions in Austria, Spain, USA and Germany. Peter was holding positions finance and acted as CFO, he was leading transformation projects and moved into general management working for Sandoz Germany. After leaving Sandoz, Peter became the CFO of the Ratiopharm Group, before its acquisition by Teva.
In 2007 Peter founded together with Claudio Albrecht the strategy consulting firm CoMeth in Slovakia before he was asked to assume the role of the Deputy CEO of the Actavis Group. As such he was a decisive player in the turn around and divestiture of the company.After the divestiture of Actavis, Peter founded with Claudio Albrecht the Zug/Switzerland based Albrecht, Prock & Partners AG. Together with Private Equity and strategic investors AP&P worked on numerous acquisition projects amongst which the take private initiative for STADA AG was the most significant. Peter also served as an acting CEO for Polpharma Group from 2013 to 2015 and serves on the board of several Pharmaceutical companies. Peter holds a Masters degree in Business Administration